Sunday, June 1, 2025

Latest

Mind Cure Enters LOI To Acquire Ephiphany360 Digital Therapeutics Platform

Mind Cure Health (CSE: MCUR) is getting into the digital therapeutics space. The company announced this morning that it entered into a non-binding letter of intent late last week to acquire Ephiphany360. Ephiphany360 is a digital, cloud-based platform focused on treating mental health.

The platform is designed to co-ordinate care between health practitioners, such as therapists, and doctors, as well as patients themselves to assist in the treatment of mental health. Ephiphany360 is designed to monitor, collect, and generate evidence based insights that is focused on optimizing treatment and improving patient outcomes.

With the platform clinically validated on more than 10,000 patients, the tech is powered by data that is said to compare treatments and outcomes in patients, which works to continuously improve the accuracy of unique patient care options. Four feasibility studies related to the tech are said to currently be underway, with the data being collected to be used as part of Ephiphany360’s application to the FDA for clearance as a Class II medical device.

“We are accelerating our move into digital therapeutics with the Epiphany360 platform to bring evidence-based insights in the diagnoses and treatment of patients suffering from mental health related illness. Technology innovation has a key role to play in modern healthcare as we look to find new and more effective ways to treat mental health. Epiphany360 will enable Mind Cure to more effectively create and evaluate products, drugs and therapies.”

Philip Tapley, Mind Cure Chairman, President, and CEO

Under the current terms of the non-binding letter of intent, Ephiany360 is to be acquired for $2.0 million, to be paid in common shares of Mind Cure. Shares are to be issued based on the ten day volume weighted average price , with shares subject to an escrow agreement upon closing. The escrow arrangement provides for 15% of the shares to be released immediately, with the remainder to be released in six equal installments, with each installment occurring every six months.

Mind Cure Health last traded at $0.71 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

Mind Cure Announces Launch Of iSTRYM, A Mental Wellness Digital Therapeutics Tool

Mind Cure Health (CSE: MCUR) has launched a digital therapeutic tool which has been designed...

Wednesday, January 6, 2021, 07:26:11 AM

Mind Cure Health: A Glance At The Latest Additions To The Advisory Team

Over the course of the last two weeks, Mind Cure Health (CSE: MCUR) has slowly...

Sunday, October 11, 2020, 03:47:00 PM

Mind Cure To See Nootropics Sold Across North America Via Body Energy Club

Mind Cure Health (CSE: MCUR) this morning released further plans related to the launch of...

Thursday, December 31, 2020, 09:17:25 AM

Mind Cure Health Begins Research Into Psychedelic Compounds

Mind Cure Health (CSE: MCUR) has reached a milestone, with the company this morning announcing...

Tuesday, December 8, 2020, 08:04:33 AM

Mind Cure Appoints Dr Ryan Hartwell As Chief Science Officer

Mind Cure Health (CSE: MCUR) has a new executive. The company this morning announced that...

Tuesday, November 10, 2020, 08:57:19 AM